trypan blue has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, BB; Gupta, SC; Murakami, A; Prasad, S; Reuter, S; Sung, B; Yadav, VR; Yamamoto, N | 1 |
| Athanasou, NA; Knowles, HJ | 1 |
2 other study(ies) available for trypan blue and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
RANKL signaling and osteoclastogenesis is negatively regulated by cardamonin.
Topics: Animals; Blotting, Western; Bone Resorption; Cell Line, Tumor; Chalcones; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Humans; I-kappa B Kinase; Mice; Monocytes; NF-kappa B; Oligonucleotides; Osteoclasts; Phosphorylation; RANK Ligand; Signal Transduction; Trypan Blue | 2013 |
Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis.
Topics: Apoptosis; Biomarkers; Bone Resorption; Cathepsin K; Cathepsins; Cell Differentiation; Cell Hypoxia; Cell Membrane; Coloring Agents; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Osteoclasts; Oxygen; Receptors, Thrombin; RNA Interference; RNA, Small Interfering; Trypan Blue | 2009 |